Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Generic delimitations, biogeography and evolution in the tribe Coleeae (Bignoniaceae), endemic to Madagascar and the smaller islands of the western Indian Ocean.

Callmander MW, Phillipson PB, Plunkett GM, Edwards MB, Buerki S.

Mol Phylogenet Evol. 2016 Mar;96:178-186. doi: 10.1016/j.ympev.2015.11.016. Epub 2015 Dec 19.

PMID:
26712485
2.

Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study.

Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chiswell K, Cyr D, Wilk A, Wang F, Rogers C, De Bruyne B; PLATFORM Investigators.

Eur Heart J. 2015 Dec 14;36(47):3359-67. doi: 10.1093/eurheartj/ehv444. Epub 2015 Sep 1.

3.

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes Care. 2015 May;38(5):940-2. doi: 10.2337/dc14-2787. Epub 2015 Mar 10.

4.

Effect of eprosartan-based antihypertensive therapy on coronary heart disease risk assessed by Framingham methodology in Canadian patients: results of the POWER survey.

Petrella RJ, Tremblay G, De Backer G, Gill DP; POWER survey Study Group.

Vasc Health Risk Manag. 2014 Jan 29;10:63-74. doi: 10.2147/VHRM.S55298. eCollection 2014.

5.

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.

Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups.

Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656. Epub 2013 Jul 17.

6.

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425. Epub 2013 Jul 1.

7.

New species from the Galoka and Kalabenono massifs: two unknown and severely threatened mountainous areas in NW Madagascar.

Callmander MW, Rakotovao C, Razafitsalama J, Phillipson PB, Buerki S, Hong-Wa C, Rakotoarivelo N, Andriambololonera S, Koopman MM, Johnson DM, Deroin T, Ravoahangy A, Solo S, Labat JN, Lowry PP 2nd.

Candollea. 2009 Jan 1;64(2):179-202.

Supplemental Content

Loading ...
Support Center